|
1 Indications And Usage Portrazza™ Is An Epidermal Growth Factor Receptor (Egfr) Antagonist Indicated, In Combination With Gemcitabine And Cisplatin, For First-Line Treatment Of Patients With Metastatic Squamous Non-Small Cell Lung Cancer. ( 1.1 ) Limitation Of Use: Portrazza Is Not Indicated For Treatment Of Non-Squamous Non-Small Cell Lung Cancer. ( 1.2 , 5.6 , 14.2 ) 1.1 Squamous Non-Small Cell Lung Cancer (Nsclc) Portrazza™ Is Indicated, In Combination With Gemcitabine And Cisplatin, For First-Line Treatment Of Patients With Metastatic Squamous Non-Small Cell Lung Cancer. 1.2 Limitation Of Use Portrazza Is Not Indicated For Treatment Of Non-Squamous Non-Small Cell Lung Cancer [See Warnings And Precautions ( 5.6 ) And Clinical Studies ( 14.2 )] .
|